Orange, CALIFORNIA4 Active Studies

Chronic Lymphocytic Leukemia Clinical Trials in Orange, CALIFORNIA

Find 4 actively recruiting chronic lymphocytic leukemia clinical trials in Orange, CALIFORNIA. Connect with local research sites and explore new treatment options.

4
Active Trials
2
Sponsors
2,302
Enrolling

Recruiting Chronic Lymphocytic Leukemia Studies in Orange

RecruitingOrange, CALIFORNIANCT01804686

A Long-term Extension Study of PCI-32765 (Ibrutinib)

The purpose of this study is to collect long-term safety and efficacy data for participants treated with ibrutinib and to provide ongoing access to ibrutinib for participants who are currently enrolle...

700 participants
Janssen Research & Development, LLC
View Study Details
RecruitingOrange, CALIFORNIANCT06073821

Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Participants With Chronic Lymphocytic Leukemia (CLL)

The main objective of this study is to compare the efficacy of sonrotoclax plus zanubrutinib versus venetoclax plus obinutuzumab in participants with chronic lymphocytic leukemia (CLL)...

652 participants
BeiGene
View Study Details
RecruitingOrange, CALIFORNIANCT06943872

A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

The goal of this study is to compare how well sonrotoclax plus obinutuzumab works versus venetoclax plus rituximab in treating adults with relapsed and/or refractory (R/R) chronic lymphocytic leukemia...

630 participants
BeiGene
View Study Details
RecruitingOrange, CALIFORNIANCT05963074

A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia

The purpose of this study is to evaluate the efficacy and safety of ibrutinib + venetoclax (I+V) and ibrutinib monotherapy regimens in which dosing of ibrutinib is either proactively reduced or reacti...

320 participants
Janssen Research & Development, LLC
View Study Details

About Chronic Lymphocytic Leukemia Clinical Trials in Orange

Chronic lymphocytic leukemia (CLL) is a slow-growing cancer of the blood and bone marrow that affects B lymphocytes. It is the most common type of adult leukemia. Treatment options include targeted therapies, chemotherapy, and immunotherapy.

There are currently 4 chronic lymphocytic leukemia clinical trials recruiting participants in Orange, CALIFORNIA. These studies are seeking a combined 2,302 participants. Research is being sponsored by Janssen Research & Development, LLC, BeiGene. Clinical trial participation is free and participants receive study-related medical care at no cost.

Chronic Lymphocytic Leukemia Clinical Trials in Orange — FAQ

Are there chronic lymphocytic leukemia clinical trials in Orange?

Yes, there are 4 chronic lymphocytic leukemia clinical trials currently recruiting in Orange, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Orange?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Orange research site will contact you about next steps.

Are clinical trials in Orange free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Orange studies also compensate for your time and travel.

What chronic lymphocytic leukemia treatments are being tested?

The 4 active trials in Orange are testing new therapies including novel drugs, biologics, and treatment approaches for chronic lymphocytic leukemia.

Data updated March 2, 2026 from ClinicalTrials.gov